Biomerica Inc (BMRA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biomerica Inc (BMRA) has a cash flow conversion efficiency ratio of -0.377x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.25 Million) by net assets ($3.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Biomerica Inc worth for the company's overall valuation and market capitalisation.
Biomerica Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Biomerica Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biomerica Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biomerica Inc ranked by their cash flow conversion efficiency. Explore Biomerica Inc (BMRA) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Polar Capital Global Financials Trust plc
LSE:PCFT
|
0.010x |
|
INDUSTRIAL MINERALS LTD
F:9ED
|
N/A |
|
Tourn International AB
ST:TOURN
|
0.052x |
|
GREENHY2 Ltd
AU:H2G
|
-0.158x |
|
Bio Green Med Solution, Inc.
NASDAQ:BGMS
|
-0.005x |
|
PVW Resources Ltd
AU:PVW
|
-1.696x |
|
Fidelity Asian Values
LSE:FAS
|
0.000x |
|
Purple Biotech Ltd
TA:PPBT
|
-0.033x |
Annual Cash Flow Conversion Efficiency for Biomerica Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Biomerica Inc from 1989 to 2025. View Biomerica Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $4.11 Million | $-3.84 Million | -0.936x | -15.04% |
| 2024-05-31 | $6.59 Million | $-5.36 Million | -0.813x | -74.21% |
| 2023-05-31 | $11.72 Million | $-5.47 Million | -0.467x | -708.86% |
| 2022-05-31 | $8.32 Million | $-480.53K | -0.058x | +89.86% |
| 2021-05-31 | $9.23 Million | $-5.25 Million | -0.569x | -88.24% |
| 2020-05-31 | $14.21 Million | $-4.30 Million | -0.302x | +46.36% |
| 2019-05-31 | $3.98 Million | $-2.24 Million | -0.564x | -107.66% |
| 2018-05-31 | $4.33 Million | $-1.17 Million | -0.271x | -68.57% |
| 2017-05-31 | $4.49 Million | $-722.86K | -0.161x | -302.63% |
| 2016-05-31 | $5.22 Million | $-208.78K | -0.040x | +44.76% |
| 2015-05-31 | $5.60 Million | $-405.48K | -0.072x | +50.34% |
| 2014-05-31 | $5.91 Million | $-862.27K | -0.146x | -161.02% |
| 2013-05-31 | $5.83 Million | $1.39 Million | 0.239x | +706.88% |
| 2012-05-31 | $4.98 Million | $147.41K | 0.030x | -61.00% |
| 2011-05-31 | $4.33 Million | $328.80K | 0.076x | +230.18% |
| 2010-05-31 | $4.06 Million | $-236.98K | -0.058x | -148.64% |
| 2009-05-31 | $4.35 Million | $-102.00K | -0.023x | +53.18% |
| 2008-05-31 | $3.88 Million | $-194.59K | -0.050x | -118.94% |
| 2007-05-31 | $1.75 Million | $463.71K | 0.265x | +173.07% |
| 2006-05-31 | $1.06 Million | $-385.17K | -0.362x | -1854.28% |
| 2005-05-31 | $3.53 Million | $72.92K | 0.021x | +196.65% |
| 2004-05-31 | $3.51 Million | $-75.03K | -0.021x | -113.52% |
| 2003-05-31 | $3.25 Million | $512.54K | 0.158x | +497.02% |
| 2002-05-31 | $3.30 Million | $-131.07K | -0.040x | -228.48% |
| 2001-05-31 | $3.52 Million | $108.95K | 0.031x | +105.93% |
| 2000-05-31 | $4.91 Million | $-2.56 Million | -0.522x | -709.72% |
| 1999-05-31 | $6.20 Million | $-400.00K | -0.065x | -200.00% |
| 1998-05-31 | $6.20 Million | $400.00K | 0.065x | -45.62% |
| 1997-05-31 | $5.90 Million | $700.00K | 0.119x | -2.71% |
| 1996-05-31 | $4.10 Million | $500.00K | 0.122x | -21.95% |
| 1995-05-31 | $3.20 Million | $500.00K | 0.156x | -48.44% |
| 1994-05-31 | $3.30 Million | $1.00 Million | 0.303x | +312.12% |
| 1993-05-31 | $2.80 Million | $-400.00K | -0.143x | +17.86% |
| 1992-05-31 | $2.30 Million | $-400.00K | -0.174x | -139.53% |
| 1991-05-31 | $2.50 Million | $1.10 Million | 0.440x | +1112.00% |
| 1990-05-31 | $4.60 Million | $-200.00K | -0.043x | +76.09% |
| 1989-05-31 | $3.30 Million | $-600.00K | -0.182x | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more